Miguel Gallego

ORCID: 0000-0002-8882-4033
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pneumonia and Respiratory Infections
  • Nosocomial Infections in ICU
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Respiratory viral infections research
  • Respiratory Support and Mechanisms
  • Lung Cancer Diagnosis and Treatment
  • Gut microbiota and health
  • Tracheal and airway disorders
  • Cystic Fibrosis Research Advances
  • Emergency and Acute Care Studies
  • Pediatric health and respiratory diseases
  • Antifungal resistance and susceptibility
  • Asthma and respiratory diseases
  • Pleural and Pulmonary Diseases
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Antibiotic Use and Resistance
  • Occupational and environmental lung diseases
  • Bone health and osteoporosis research
  • Head and Neck Cancer Studies
  • Radiomics and Machine Learning in Medical Imaging
  • Occupational exposure and asthma
  • Inhalation and Respiratory Drug Delivery
  • Respiratory and Cough-Related Research
  • Influenza Virus Research Studies

Corporació Sanitària Parc Taulí
2012-2024

Universitat Autònoma de Barcelona
2009-2024

Institute of Research and Innovation Parc Tauli
2013-2024

Centro de Investigación Biomédica en Red de Enfermedades Respiratorias
2014-2024

Instituto de Salud Carlos III
2013-2024

Vall d'Hebron Institut de Recerca
2024

Vall d'Hebron Hospital Universitari
2024

Universidad Complutense de Madrid
2024

Deleted Institution
2012-2022

University Hospital St. Marina
2018

The use of microbiologic investigations in routine clinical practice, their value guiding antibiotic prescription, and influence on outcome were prospectively studied 113 consecutive adults who developed ventilator-associated pneumonia (VAP). Blood cultures performed 78.7% cases, protected specimen brushing 95.5%, bronchoalveolar lavage only 45.1%. No causative agent was identified 13 episodes (11.5%), results microbial tests directed a change therapy 43 (38.0%). Bronchoscopic revealed...

10.1164/ajrccm.156.1.9607030 article EN American Journal of Respiratory and Critical Care Medicine 1997-07-01

ABSTRACT Bronchial colonization by potentially pathogenic microorganisms (PPMs) is often demonstrated in chronic obstructive pulmonary disease (COPD), but culture-based techniques identify only a portion of the bacteria mucosal surfaces. The aim study was to determine changes bronchial microbiome COPD associated with severity disease. patients analyzed 16S rRNA gene amplification and pyrosequencing sputum samples obtained during stable Seventeen were studied (forced expiratory volume first...

10.1128/jcm.01967-14 article EN Journal of Clinical Microbiology 2014-09-25

To develop a severity assessment tool to predict mortality in community-acquired pneumonia (CAP) patients intensive care unit (ICU), comparing its performance with Acute Physiology and Chronic Health Evaluation (APACHE) II score American Thoracic Society/Infectious Disease Society of America (ATS/IDSA) criteria as prognostic index CAP requiring ICU admission.Secondary analysis prospective observational cohort study.Thirty-three ICUs.Five hundred twenty-nine adult admission.A was developed...

10.1097/ccm.0b013e318194b021 article EN Critical Care Medicine 2009-01-26

The bronchial microbiome in severe COPD during stability and exacerbation patients chronically colonised by Pseudomonas aeruginosa (PA), has not been defined. Our objective was to determine the characteristics of P. its changes exacerbation. with disease frequent exacerbations were categorised according chronic colonisation aeruginosa. Sputum samples obtained exacerbation, cultured, analysed 16S rRNA gene amplification pyrosequencing. Sixteen included, 5 them showing genus had significantly...

10.1007/s10096-013-2044-0 article EN cc-by European Journal of Clinical Microbiology & Infectious Diseases 2014-01-21

Patients with severe chronic obstructive pulmonary disease (COPD) are at increased risk of infection by P. aeruginosa. The specific role bronchiectasis in both and colonization this microorganism COPD, however, remains ill defined. To evaluate the prevalence factors for aeruginosa recovery from sputum outpatients characterizing isolates pulsed-field gel electrophoresis (PFGE) focusing on influence these patients. A case-cohort study 118 patients COPD attended a Respiratory Day Unit an acute...

10.1186/1471-2466-14-103 article EN cc-by BMC Pulmonary Medicine 2014-06-26

Pneumocystis jirovecii pneumonia (PJP) is an opportunistic, life-threatening disease commonly affecting immunocompromised patients. The distribution of predisposing diseases or conditions in critically ill patients admitted to intensive care unit (ICU) and subjected diagnostic work-up for PJP has seldom been explored.The primary objective the study was describe characteristics ICU workup PJP. secondary objectives were: (i) assess demographic clinical variables associated with PJP; (ii)...

10.1186/s13054-023-04608-1 article EN cc-by Critical Care 2023-08-24

To evaluate the effect of discordant empirical therapy on outcome in bacteremic pneumococcal community-acquired pneumonia.Prospective observational study.A 600-bed teaching hospital with a reference area 400,000 inhabitants.All patients aged > or =18 yrs diagnosis pneumonia whose blood cultures, obtained within first 48 hrs hospitalization, demonstrated growth Streptococcus pneumoniae were included study.Discordant was defined as failure to administer an antibiotic vitro activity against...

10.1097/01.ccm.0000114817.58194.bf article EN Critical Care Medicine 2004-03-01

The influence of infecting serotype group on outcome in bacteraemic pneumococcal pneumonia remains unclear. We performed a prospective, 10-yr observational study an 800-bed teaching hospital. 299 adults diagnosed with whose blood cultures showed growth Streptococcus pneumoniae were included the study. High invasive disease potential (H) serotypes 1, 5 and 7F, which served as reference category, compared low (L) (3, 6A, 6B, 8, 19F, 23F) other (O) (non-H, non-L). was determined for each after...

10.1183/09031936.00176309 article EN European Respiratory Journal 2010-02-11

Background. The 13-valent pneumococcal conjugate vaccine (PCV13) has recently been approved for use in immunocompromised adults. However, it is unclear whether there an association between specific underlying conditions and infection by individual serotypes. objective was to determine the prevalence of serotypes covered PCV13 a cohort patients with invasive disease respiratory origin are risk factors each serotype. Methods. An observational study adults hospitalized 2 Spanish hospitals...

10.1093/cid/cit640 article EN Clinical Infectious Diseases 2013-09-24

The course of chronic obstructive pulmonary disease (COPD) is frequently aggravated by exacerbations, and changes in the composition activity microbiome may be implicated their appearance. aim this study was to analyse gene content microbial community bronchial secretions COPD patients both stability exacerbation. Taxonomic data were obtained 16S rRNA amplification pyrosequencing, metabolic information through shotgun metagenomics, using Metagenomics RAST server (MG-RAST), PICRUSt...

10.1371/journal.pone.0144448 article EN cc-by PLoS ONE 2015-12-03

C-reactive protein (CRP) measurement has proven valuable for detecting exacerbations, but its usefulness in predicting etiology remains controversial. Likewise, potential value as a marker of severity, which is well established patients with pneumonia, unproven chronic obstructive pulmonary disease (COPD) exacerbations.A cohort study 118 severe COPD and acute infectious exacerbations were included followed up over 1 year. Episodes meeting Anthonisen's criteria type I-II evaluated, analyzing...

10.2147/copd.s117129 article EN cc-by-nc International Journal of COPD 2016-10-01
Manuela Carugati Stefano Aliberti Giovanni Sotgiu Francesco Blasi Andrea Gori and 95 more Rosario Menéndez Milena Encheva Miguel Gallego Pedro Leuschner Silvia Ruiz-Buitrago Salvatore Battaglia Riccardo Fantini Sergi Pascual-Guàrdia Judith Marín‐Corral Marcos I. Restrepo Patricia Aruj Silvia Attorri Enrique Barimboim Juan Pablo Caeiro María Isabel Garzón Victor Hugo Cambursano Adrián Ceccato Julio Chertcoff Florencia Lascar Fernando Di Tulio Ariel Cordon Díaz Lautaro De Vedia María Cristina Ganaha Sandra Lambert Gustavo Lopardo Carlos M. Luna Alessio Gerardo Malberti Nora Morcillo Silvina Tártara Claudia Pensotti Betiana Pereyra Pablo Scapellato Juan Pablo Stagnaro Sonali Shah Felix Lötsch Florian Thalhammer Jean‐Louis Vincent Kurt Anseeuw Camille A Francois Eva Van Braeckel Marcel Zannou Djimon Jules Bashi Dodo Roger Simone Aranha Nouér Peter Chipev Milena Encheva Darina Miteva Diana Petkova Balkissou Adamou Dodo Mbatchou Ngahane Bertrand Hugo Ning Shen Jinfu Xu Carlos Andres Bustamante Rico Ricardo Buitrago Fernando Jose Pereira Paternina Kayembe Ntumba Jean-Marie Vesna Vladic Carevic Marko Jakopović Mateja Janković Zinka Matković Ivan Mitrecic Marie-Laure Bouchy Jacobsson Anette Bro Christensen Uff e Christian HeitmannBødtger C Meyer Andreas Vestergaard Jensen Gertrud Baunbæk-knudsen Pelle Trier Petersen Stine Linding Andersen Ibrahim El-Said Abd El-Wahhab Nesreen Elsayed Morsy Hanaa Shafiek Eman Sobh Fabrice Bertrand Christian Brun‐Buisson Étienne de Montmollin Muriel Fartoukh Jonathan Messika Pierre Tattevin Michael Dreher Martin Kolditz Matthias Meisinger Mathias W. Pletz Stefan Hagel Jan Rupp Tom Schaberg Marc Spielmanns Beatrice Siaw-Lartey Katerina Dimakou Dimosthenis Papapetrou Evdoxia Tsigou Dimitrios Ampazis Mohit Bhatia Raja Dhar

10.1007/s10096-020-03870-3 article EN European Journal of Clinical Microbiology & Infectious Diseases 2020-04-03

Staging of mediastinal lymph nodes in non-small cell lung cancer (NSCLC) is mandatory. The maximum Standard Uptake Value (SUVmax) obtained using F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) the best non-invasive technique available for this evaluation, but its performance varies from center to center. aim present study was identify FDG-PET predictors malignancy that are able minimize intercenter variability and improve selection subsequent staging procedures. A multicenter...

10.1186/s12890-016-0338-6 article EN cc-by BMC Pulmonary Medicine 2016-12-01
Coming Soon ...